ID   GYRA_MYCS2              Reviewed;         842 AA.
AC   P48354; A0QNE1; I7FC85;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   05-FEB-2025, entry version 146.
DE   RecName: Full=DNA gyrase subunit A {ECO:0000255|HAMAP-Rule:MF_01897};
DE            EC=5.6.2.2 {ECO:0000255|HAMAP-Rule:MF_01897};
GN   Name=gyrA {ECO:0000255|HAMAP-Rule:MF_01897};
GN   OrderedLocusNames=MSMEG_0006, MSMEI_0008;
OS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium
OS   smegmatis).
OC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Mycobacteriales;
OC   Mycobacteriaceae; Mycolicibacterium.
OX   NCBI_TaxID=246196;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBUNIT, AND ACTIVITY
RP   REGULATION.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=8878580; DOI=10.1128/aac.40.9.2054;
RA   Revel-Viravau V., Truong Q.C., Moreau N., Jarlier V., Sougakoff W.;
RT   "Sequence analysis, purification, and study of inhibition by 4-quinolones
RT   of the DNA gyrase from Mycobacterium smegmatis.";
RL   Antimicrob. Agents Chemother. 40:2054-2061(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RA   Fleischmann R.D., Dodson R.J., Haft D.H., Merkel J.S., Nelson W.C.,
RA   Fraser C.M.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=17295914; DOI=10.1186/gb-2007-8-2-r20;
RA   Deshayes C., Perrodou E., Gallien S., Euphrasie D., Schaeffer C.,
RA   Van-Dorsselaer A., Poch O., Lecompte O., Reyrat J.-M.;
RT   "Interrupted coding sequences in Mycobacterium smegmatis: authentic
RT   mutations or sequencing errors?";
RL   Genome Biol. 8:R20.1-R20.9(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=18955433; DOI=10.1101/gr.081901.108;
RA   Gallien S., Perrodou E., Carapito C., Deshayes C., Reyrat J.-M.,
RA   Van Dorsselaer A., Poch O., Schaeffer C., Lecompte O.;
RT   "Ortho-proteogenomics: multiple proteomes investigation through orthology
RT   and a new MS-based protocol.";
RL   Genome Res. 19:128-135(2009).
CC   -!- FUNCTION: A type II topoisomerase that negatively supercoils closed
CC       circular double-stranded (ds) DNA in an ATP-dependent manner
CC       (PubMed:8878580) to modulate DNA topology and maintain chromosomes in
CC       an underwound state. Negative supercoiling favors strand separation,
CC       and DNA replication, transcription, recombination and repair, all of
CC       which involve strand separation. Also able to catalyze the
CC       interconversion of other topological isomers of dsDNA rings, including
CC       catenanes and knotted rings. Type II topoisomerases break and join 2
CC       DNA strands simultaneously in an ATP-dependent manner.
CC       {ECO:0000255|HAMAP-Rule:MF_01897, ECO:0000269|PubMed:8878580}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-dependent breakage, passage and rejoining of double-
CC         stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01897};
CC   -!- ACTIVITY REGULATION: Inhibited by 4-quinoline drugs (nalidixic acid,
CC       ciprofloxacin, ofloxacin), although it is much less sensitive than the
CC       corresponding enzyme from E.coli (PubMed:8878580).
CC       {ECO:0000269|PubMed:8878580}.
CC   -!- SUBUNIT: Heterotetramer, composed of two GyrA and two GyrB chains
CC       (PubMed:8878580). In the heterotetramer, GyrA contains the active site
CC       tyrosine that forms a transient covalent intermediate with DNA, while
CC       GyrB binds cofactors and catalyzes ATP hydrolysis. {ECO:0000255|HAMAP-
CC       Rule:MF_01897, ECO:0000269|PubMed:8878580}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01897}.
CC   -!- MISCELLANEOUS: Few gyrases are as efficient as E.coli at forming
CC       negative supercoils. Not all organisms have 2 type II topoisomerases;
CC       in organisms with a single type II topoisomerase this enzyme also has
CC       to decatenate newly replicated chromosomes. {ECO:0000255|HAMAP-
CC       Rule:MF_01897}.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase GyrA/ParC subunit
CC       family. {ECO:0000255|HAMAP-Rule:MF_01897}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X94224; CAA63918.1; -; Genomic_DNA.
DR   EMBL; CP000480; ABK69994.1; -; Genomic_DNA.
DR   EMBL; CP001663; AFP36493.1; -; Genomic_DNA.
DR   RefSeq; WP_003891334.1; NZ_SIJM01000001.1.
DR   RefSeq; YP_884429.1; NC_008596.1.
DR   AlphaFoldDB; P48354; -.
DR   SMR; P48354; -.
DR   STRING; 246196.MSMEG_0006; -.
DR   PaxDb; 246196-MSMEI_0008; -.
DR   GeneID; 93454933; -.
DR   KEGG; msb:LJ00_00030; -.
DR   KEGG; msg:MSMEI_0008; -.
DR   KEGG; msm:MSMEG_0006; -.
DR   PATRIC; fig|246196.19.peg.6; -.
DR   eggNOG; COG0188; Bacteria.
DR   OrthoDB; 9806486at2; -.
DR   Proteomes; UP000000757; Chromosome.
DR   Proteomes; UP000006158; Chromosome.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0009330; C:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0034335; F:DNA negative supercoiling activity; IDA:UniProtKB.
DR   GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule.
DR   GO; GO:0006261; P:DNA-templated DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   CDD; cd00187; TOP4c; 1.
DR   FunFam; 1.10.268.10:FF:000001; DNA gyrase subunit A; 1.
DR   FunFam; 2.120.10.90:FF:000001; DNA gyrase subunit A; 1.
DR   FunFam; 3.90.199.10:FF:000001; DNA gyrase subunit A; 1.
DR   FunFam; 3.30.1360.40:FF:000008; DNA topoisomerase (ATP-hydrolyzing); 1.
DR   Gene3D; 3.30.1360.40; -; 1.
DR   Gene3D; 2.120.10.90; DNA gyrase/topoisomerase IV, subunit A, C-terminal; 1.
DR   Gene3D; 3.90.199.10; Topoisomerase II, domain 5; 1.
DR   Gene3D; 1.10.268.10; Topoisomerase, domain 3; 1.
DR   HAMAP; MF_01897; GyrA; 1.
DR   InterPro; IPR005743; GyrA.
DR   InterPro; IPR006691; GyrA/parC_rep.
DR   InterPro; IPR035516; Gyrase/topoIV_suA_C.
DR   InterPro; IPR013760; Topo_IIA-like_dom_sf.
DR   InterPro; IPR013758; Topo_IIA_A/C_ab.
DR   InterPro; IPR013757; Topo_IIA_A_a_sf.
DR   InterPro; IPR002205; Topo_IIA_dom_A.
DR   InterPro; IPR050220; Type_II_DNA_Topoisomerases.
DR   NCBIfam; TIGR01063; gyrA; 1.
DR   PANTHER; PTHR43493:SF5; DNA GYRASE SUBUNIT A, CHLOROPLASTIC_MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43493; DNA GYRASE/TOPOISOMERASE SUBUNIT A; 1.
DR   Pfam; PF03989; DNA_gyraseA_C; 6.
DR   Pfam; PF00521; DNA_topoisoIV; 1.
DR   SMART; SM00434; TOP4c; 1.
DR   SUPFAM; SSF101904; GyrA/ParC C-terminal domain-like; 1.
DR   SUPFAM; SSF56719; Type II DNA topoisomerase; 1.
DR   PROSITE; PS52040; TOPO_IIA; 1.
PE   1: Evidence at protein level;
KW   Antibiotic resistance; ATP-binding; Cytoplasm; DNA-binding; Isomerase;
KW   Nucleotide-binding; Reference proteome; Topoisomerase.
FT   CHAIN           1..842
FT                   /note="DNA gyrase subunit A"
FT                   /id="PRO_0000145242"
FT   DOMAIN          42..511
FT                   /note="Topo IIA-type catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01384"
FT   REGION          822..842
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           538..544
FT                   /note="GyrA-box"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01897"
FT   ACT_SITE        130
FT                   /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01897"
SQ   SEQUENCE   842 AA;  93183 MW;  50AE5DBE80ED45DD CRC64;
     MTDTTLPPEG EAHDRIEPVD IQQEMQRSYI DYAMSVIVGR ALPEVRDGLK PVHRRVLYAM
     YDSGFRPDRS HAKSARSVAE TMGNYHPHGD ASIYDTLVRM AQPWSLRYPL VDGQGNFGSP
     GNDPPAAMRY TEARLTPLAM EMLREIDEET VDFIPNYDGR VQEPTVLPSR FPNLLANGSG
     GIAVGMATNI PPHNLGELAE AVYWCLENYE ADEEATCEAV MERVKGPDFP TSGLIVGTQG
     IEDTYKTGRG SIKMRGVVEI EEDSRGRTSI VITELPYQVN HDNFITSIAE QVRDGKLAGI
     SNIEDQSSDR VGLRIVVELK RDAVAKVVLN NLYKHTQLQT SFGANMLSIV DGVPRTLRLD
     QLIRLYVDHQ LDVIVRRTRY RLRKANERAH ILRGLVKALD ALDEVIALIR ASQTVDIARA
     GLIELLDIDD IQAQAILDMQ LRRLAALERQ KIVDDLAKIE AEIADLEDIL AKPERQRGIV
     RDELKEIVDK HGDARRTRIV PADGEVSDED LIAREDVVVT ITETGYAKRT KTDLYRSQKR
     GGKGVQGAGL KQDDMVNHFF VCSTHDWILF FTTQGRVYRA KAYELPEASR TARGQHVANL
     LAFQPEERIA QVIQIKSYED APYLVLATRN GLVKKSKLSD FDSNRSGGIV AINLREGDEL
     VGAVLCSAED DLLLVSANGQ SIRFSATDEA LRPMGRATSG VQGMRFNEDD RLLSLNVVRP
     DTYLLVATSG GYAKRTSIDE YSVQGRGGKG ILTIQYDRKR GSLVGALIVD DDTELYAITS
     TGGVIRTAAR QVRKAGRQTK GVRLMNLAEG DTLIAIARNA DEDEAAESIS ESDADTAESP
     EA
//
